ENSC · Ensysce Biosciences Inc
United States · RS rating 72 · As of 2026-10-14
| Price | 0.56 USD |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 97 / 97 / 7 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 32 / 60 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +41.9% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +78.2% |
| Market cap (USD) | $3.9M |